EN DE

Shanghai Chicmax Cosmetic Co (2145) Fair Value & Analysis

Consumer Defensive · HK · Market cap HK$10.9B

SC Shanghai Chicmax Cosmetic Co 2145 · HK
PriceHK$23.48
Fair ValueHK$48.33
Upside+105.8%
Quality67/100
Watch Shanghai Chicmax Cosmetic Co for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 12.0% net margin
Low debt · generates free cash flow
4.59% dividend yield
Ranks above peers (11/14)
Wide moat 72/100
Evidence: High Range HK$36.36 – HK$130.74 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated 6 days ago

Share price −17.2% over the past month.

A solid business, screening 106% undervalued on our models.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price is below even our cautious bear case (HK$36.36). The market is more pessimistic than our downside scenario.
  • The model range is unusually wide (HK$36.36 to HK$130.74). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

HK$99.97 HK$18.66 Fair Value HK$48.33 Dec 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

44‑month range HK$18.66 – HK$99.97 · fair‑value band HK$36.36 – HK$130.74 · the HK$23.48 price screens below the HK$48.33 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Shanghai Chicmax Cosmetic Co (2145) currently trades at HK$23.48, while our model-based Fair Value estimate is HK$48.33, implying the stock looks roughly 105.8% undervalued today. The Quality Score stands at 67/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Shanghai Chicmax Cosmetic Co generated revenue of HK$9.2B at a net margin of 12.0%. Revenue grew 54.1% year over year. It earns a return on equity of 45.2%. The balance sheet holds a net cash position of HK$177M. Fundamentals as of Aug 13, 2026

Our scenario range runs from HK$36.36 (bear case) to HK$130.74 (bull case); at HK$23.48, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat. The share trades about 77% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at 106%, 2145 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF HK$29.50 HK$56.54 HK$100.86 80
Residual Income HK$19.25 HK$24.85 HK$182.94 76
Rev-Margin DCF HK$32.30 HK$58.10 HK$111.41 74
All 26 models by family
DCF Models
FCF DCF HK$31.23 HK$47.98 HK$101.30 38
Owner Earnings HK$32.32 HK$70.95 HK$152.06 31
5Y Revenue Exit HK$29.62 HK$51.06 HK$96.06 39
5Y EBITDA Exit HK$33.35 HK$58.61 HK$108.19 41
5Y P/E Exit HK$42.97 HK$97.63 HK$172.83 38
10Y Revenue Exit HK$29.50 HK$65.31 HK$89.02 36
10Y EBITDA Exit HK$33.32 HK$73.35 HK$143.65 37
10Y P/E Exit HK$40.35 HK$94.08 HK$184.05 35
Earnings-Based
Graham-Dodd HK$18.84 HK$131.35 HK$184.34 54
Lynch FV HK$63.25 HK$90.35 HK$117.46 50
PEG = 1.0 HK$63.25 HK$90.35 HK$117.46 46
EPV HK$22.09 HK$25.44 HK$28.36 59
Dividend Discount
Gordon GGM HK$14.05 HK$29.22 HK$46.35 70
DDM Multi-Stage HK$14.05 HK$24.64 HK$30.66 61
Multiples
P/E Multiple HK$43.63 HK$58.17 HK$72.71 63
P/S Multiple HK$27.67 HK$36.89 HK$46.11 58
P/B Multiple HK$28.70 HK$38.26 HK$47.83 55
EV/EBIT HK$36.65 HK$48.18 HK$59.72 53
EV/EBITDA HK$32.91 HK$43.21 HK$53.50 54
EV/Revenue HK$26.24 HK$36.62 HK$46.99 43
Asset-Based
NCAV (Graham) HK$3.48 HK$4.66 HK$6.96 50
Growth DCF
Growth DCF HK$29.50 HK$56.54 HK$100.86 80
Rev-Margin DCF HK$32.30 HK$58.10 HK$111.41 74
Economic Profit
Residual Income HK$19.25 HK$24.85 HK$182.94 76
ROIC Compounder HK$27.81 HK$40.99 HK$58.38 72
Growth Earnings
Growth-Adj P/E HK$83.84 HK$119.76 HK$155.69 68

Widest divergence: Growth Earnings (HK$119.76) versus Asset-Based (HK$4.66). Highest evidence: Growth DCF (80).

Notify me when 2145 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) HK$9.2B
Revenue growth (YoY) +54.1%
Net margin 12.0%
Return on equity 45.2%
Free cash flow HK$691M FY2025
P/E ratio 8.6 as of Jul 2, 2026
More key figures
Operating margin 11.5%
EPS (TTM) HK$1.32
Dividend yield 4.6%
EPS growth (YoY) +52.2%
Net cash HK$177M FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 67 · Market factors (momentum, volatility) 16

Profitability 91
Margins and returns on capital today
Quality Growth 63
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 86
Balance sheet, leverage, solvency risk
Investment 37
Disciplined investing over empire-building
Low Volatility 54
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 65
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics in Mainland China and internationally.

Full company description

Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics in Mainland China and internationally. The company offers mass and premium skincare; maternity, childcare, and teenage skin care; washing and personal care; makeup; dermocosmetics; face masks; and haircare and toiletry products under the KANS, One Leaf, Baby Elephant, asanami, KYOCA, newpage, ARMIYO, and ATISER brands. It also provides enterprise management, property leasing, and transportation services. The company sells its products through online and offline channels to retailers and distributors. The company was formerly known as Shanghai Kaka Cosmetic Co., Ltd. and changed its name to Shanghai Chicmax Cosmetic Co., Ltd. in 2020. Shanghai Chicmax Cosmetic Co., Ltd. was founded in 2002 and is headquartered in Shanghai, the People's Republic of China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Shanghai Chicmax Cosmetic Co reported revenue of HK$9.2B in FY2025 versus HK$3.6B in FY2021, a compound +26.2%/yr. Reported net income was HK$1.1B in FY2025, compounding +34.3%/yr from FY2021.

Growth Quality 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
HK$9.2B
Latest YoY
+35.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+50.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+22.1%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+21.3%
Revenue +26.2%/yr
FY21 HK$3.6B
FY22 HK$2.7B
FY23 HK$4.2B
FY24 HK$6.8B
FY25 HK$9.2B
Net income +34.3%/yr
FY21 HK$339M
FY22 HK$147M
FY23 HK$461M
FY24 HK$781M
FY25 HK$1.1B

Watch 2145: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Shanghai Chicmax Cosmetic Co Fair Value". https://www.fairvalue-calculator.com/stock/2145

Peer Group

Household & Personal Products · 248 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Above median
Fair Value upside +106% · Top 25%
Return on equity (TTM) 45% · Top 25%
Return on assets 16% · Top 25%
Net margin (TTM) 12% · Top 25%
Operating margin (TTM) 11% · Above median
Revenue growth 54% · Top 25%
Dividend yield (TTM) 5.3% · Top 25%

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 8.6× · Cheaper than 75% of peers
P/B 3.94× · Pricier than 75% of peers
P/S (TTM) 1.19× · Pricier than median
P/FCF 2.0× · Pricier than median
EV/EBITDA 8.4× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 27
FUTURE100 · sector 4
PAST100 · sector 26
HEALTH100 · sector 98
DIVIDEND100 · sector 52

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $144.26 $108.16 -25%
Unilever PLC ULN 1,080 MXN 973.58 MXN -10%
Hindustan Unilever Limited HINDUNILVR ₹2,063 ₹789.46 -62%
Essity AB ESSITYA kr 276.50 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹936.90 ₹367.64 -61%
Marico Limited MARICO ₹841.55 ₹233.05 -72%
APR Co 278470 396,500 KRW 137,521 KRW -65%
Dabur India Limited DABUR ₹411.25 ₹175.59 -57%
PT Unilever Indonesia Tbk UNVR 1,760 IDR 1,928 IDR +10%
Amorepacific Corporation 090430 135,700 KRW 84,785 KRW -38%

Compare Shanghai Chicmax Cosmetic Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Shanghai Chicmax Cosmetic Co (2145) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of HK$48.33 versus a price of HK$23.48, about +106% (undervalued).
What is the fair value of 2145?
Our model-based fair value for Shanghai Chicmax Cosmetic Co is HK$48.33 (as of Aug 13, 2026), built from audited fundamentals. The current price: HK$23.48.
What is the quality score of 2145?
Shanghai Chicmax Cosmetic Co has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Shanghai Chicmax Cosmetic Co (2145)?
Shanghai Chicmax Cosmetic Co reported trailing-twelve-month revenue of about HK$9.2B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 2145?
The net profit margin of Shanghai Chicmax Cosmetic Co is about 12.0%, meaning it keeps roughly 12.0% of revenue as net income. Based on the latest reported figures.
Does Shanghai Chicmax Cosmetic Co pay a dividend?
Shanghai Chicmax Cosmetic Co currently shows a dividend yield of about 4.59% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Shanghai Chicmax Cosmetic Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.